Patent details

Basic Information

Publication number:

EP1625209

PCT Application Number:

PCT/US/2004/014064

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP047759469

PCT Publication Number:

WO/2005/001025

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

French Title of Invention:

HYBRIDES MONOMERES/DIMERES CHIMERIQUES D'IMMUNOGLOBULINE

German Title of Invention:

CHIMÄRISCHE IMMUNGLOBULIN-MONOMER-DIMER-HYBRIDE

SPC Number:

92991

Dates

Filing date:

06/05/2004

Grant date:

17/07/2013

EP Publication Date:

17/07/2013

PCT Publication Date:

06/01/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/02/2006

EP B1 Publication Date:

17/07/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/05/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/06/2017

 

 

Name:

Bioverativ Therapeutics Inc.

Address:

225 Second Avenue, Waltham MA 02451, United States (US)

History of Owners

From:

17/06/2015

To:

28/06/2017

Name:

BIOGEN HEMOPHILIA INC.

Address:

250 BINNEY STREET, CAMBRIDGE, MA 02142, United States (US)

From:

06/05/2004

To:

16/06/2015

Name:

BIOGEN IDEC HEMOPHILIA INC.

Address:

9 Fourth Avenue, Waltham, MA 02451, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

16/10/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

LOW Susan, C.

Address:

United States (US)

2

Name:

RIVERA Daniel, S.

Address:

United States (US)

3

Name:

BITONTI Alan, J.

Address:

United States (US)

4

Name:

PETERS Robert, T.

Address:

United States (US)

5

Name:

STATTEL James, M.

Address:

United States (US)

6

Name:

MEZO Adam, R.

Address:

United States (US)

Priority

1

Priority Number:

469600 P

Priority Date:

06/05/2003

Priority Country:

United States (US)

2

Priority Number:

487964 P

Priority Date:

17/07/2003

Priority Country:

United States (US)

3

Priority Number:

539207 P

Priority Date:

26/01/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 14/475;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20170000215A

Date Registered:

28/06/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Bioverativ Therapeutics Inc.

Address:

225 Second Avenue, Waltham MA 02451, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/04/2023

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
29/06/2017	Outgoing Correspondence	1
28/06/2017	Request For Change	6